Hence, we propose that CD164 overexpression increases cell proliferation and chemoresistance via the PI3K/Akt/mTOR pathway, resulting in the conversion of normal human bronchial epithelial cell to tumor-initiating cells (Figure 10). This evidence concerns the gene CD164 and neoplasm.